| Literature DB >> 34033147 |
Jeylan Aslan1, Michael A Shipstone1, Louise M Sullivan2.
Abstract
Canine cutaneous epitheliotropic T-cell lymphoma (CETL) is associated with a poor prognosis and without consistently beneficial treatment options. This case report describes a 9-year-old Staffordshire bull terrier with CETL treated with oclacitinib (0.7 mg/kg twice daily), resulting in partial remission that was maintained for three months. Further studies are warranted.Entities:
Year: 2021 PMID： 34033147 DOI： 10.1111/vde.12976
Source DB: PubMed Journal: Vet Dermatol ISSN： 0959-4493 Impact factor: 1.589